ATHX Bulls vs Bears 6/18/15 v1

Bulls vs Bears updated 6/18/25

Bullish

• Potential supplement to tPA for stroke treatment by providing longer treatment "window"
• Even though exploratory Phase 2 stroke trial failed to meet prim. endpt, study indicate promising result at earlier time-point( < 36 h );
• Prepared for launch of grant-supported Phase 2 AMI study at multiple sites, planned for 2nd quarter 2015;
• Acute MI favorable phase 1, plan Ph2 in Q2 2015;
• Acute respiratory Distress Syndrome phase 2a trial in UK, plan Q2 1015;
• Hematopoietic Stem Cell Transplant for radiation patients, Ph 1 completed

Bearish

• Exploratory Phase 2 trial failed to meet prim. endpoint on 4/14/15
• As of 6/2/15 Insider sell 3 mo (-128611_Sell/Tot 17/0; 12 mo (-12673, Buy/Tot 57/63 net trades) 
• Inflammatory Bowel Syndrome - Ph2 results show no efficacy. Pfizer to terminate effective July 2015 
• Will Chugai pay $7M to continue collab on ischemic stroke 
• From Q1 2015 call, stroke Phase 2b trial will happen after summer